Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
LUCD
LUCD
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
LUCD News
Lucid Diagnostics Reports Strong Q4 2025 Earnings and VA Contract Win
4d ago
seekingalpha
Lucid Diagnostics Reports Q4 2025 Earnings Highlights
4d ago
Yahoo Finance
Lucid Diagnostics Reports Q4 Highlights and Revenue Growth
4d ago
PRnewswire
Lucid Diagnostics Q4 Earnings Report Analysis
4d ago
seekingalpha
Citi Initiates Buy Rating on Lucid with $17 Price Target
Mar 19 2026
CNBC
Uber to Invest $1.25 Billion in Rivian for Robotaxi Deployment
Mar 19 2026
CNBC
PAVmed to Host Business Update Conference Call
Mar 16 2026
PRnewswire
PAVmed to Host Business Update Conference Call
Mar 16 2026
Newsfilter
Lucid Diagnostics to Host Business Update Conference Call
Mar 12 2026
Newsfilter
Supreme Court Strikes Down Trump's Tariffs, New 15% Levy Announced
Feb 23 2026
CNBC
PAVmed Secures $30 Million in Series D Preferred Stock Offering
Feb 04 2026
PRnewswire
PAVmed Subsidiary Secures VA Contract for EsoGuard Test, Expanding Access to Over 9 Million Veterans
Jan 22 2026
Benzinga
Lucid Diagnostics Secures VA Contract for EsoGuard, Boosting PAVmed Stock by 291%
Jan 21 2026
Benzinga
PAVmed Subsidiary Wins VA Contract for Esophageal Precancer Testing, Shares Surge 250%
Jan 21 2026
stocktwits
Lucid Diagnostics (LUCD) Secures VA Contract for EsoGuard Esophageal DNA Test at Medicare Pricing
Jan 21 2026
seekingalpha
Lucid Diagnostics Secures VA Contract for EsoGuard Test, Expanding Access to 9 Million Veterans
Jan 21 2026
Newsfilter
Show More News
